aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ATYR is expected to report earnings to fall 39.50% to -15 cents per share on March 12
Q4'25
Est.
$-0.16
Q3'25
Missed
by $0.09
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.05
The last earnings report on November 06 showed earnings per share of -25 cents, missing the estimate of -17 cents. With 5.88M shares outstanding, the current market capitalization sits at 70.44M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATYR showed earnings on November 06, 2025. You can read more about the earnings report here.